ASCO 2016 | Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA

Philip Mack

Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Share this video  
Similar topics
Related videos
1:27
A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma
Jae-Lyun Lee
1:15
Changing kidney cancer treatment landscape
Ignacio Duran
5:12
Darolutamide for nmCRPC: results of the ARAMIS trial
Iris Kuss
4:21
COACH trial update: GemOx vs. GCb in cisplatin-unfit advanced urothelial carcinoma
Jae-Lyun Lee
2:45
Interaction of darolutamide with substrates of CYPs and P-gp
Christian Zurth
Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer, Genitourinary Cancer, Gynecological Cancer, Gynecological Cancer, Lung Cancer, Skin Cancer
ASCO 2016
Press Brief
3rd June 2016
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals